2017
DOI: 10.1007/s11940-017-0464-3
|View full text |Cite
|
Sign up to set email alerts
|

Spinal Cord Infarcts: Risk Factors, Management, and Prognosis

Abstract: There are no standard guidelines for treatment of spinal cord ischemia due to how rare it is and the diverse etiology and presentations involved. In addition, to date, there have been no large clinical trials examining ideal pharmacologic treatment options for spinal cord infarct. In our practice, we rely on hemodynamic augmentation initiated as soon as possible. Otherwise, treatment is usually geared towards the etiology of spinal cord ischemia. For instance, spinal cord ischemia occurring after aortic aneury… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
47
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 37 publications
(48 citation statements)
references
References 42 publications
1
47
0
Order By: Relevance
“…Vertebral body infarction is known as a confirmatory sign of SCI, and it was observed in 35.7% of the patients in the present study. This rate was similar to those of previous reports (5,44).…”
Section: Discussionsupporting
confidence: 93%
“…Vertebral body infarction is known as a confirmatory sign of SCI, and it was observed in 35.7% of the patients in the present study. This rate was similar to those of previous reports (5,44).…”
Section: Discussionsupporting
confidence: 93%
“…When SCI remains in question after initial evaluation, follow-up imaging demonstrating chronic focal cystic myelomalacia (Figure 1) supports vascular sequelae as opposed to myelitis. 22 Unfortunately, no therapies are proven as effective to treat spontaneous SCI. 23,24 Lumbar drainage and blood pressure augmentation are used for SCI in the setting of aortic surgery, 23,25,26 but there are no data to support these strategies in spontaneous SCI.…”
Section: Discussionmentioning
confidence: 99%
“…2 3 Rarely, IVLBCL may masquerade as SCI. 4 SCI has identifiable etiologies including aortic disease, thrombosis and atherosclerosis 5 ; however, these risk factors were absent in this case. Thus, the findings of this case underscore the importance of including IVLBCL as a critical differential diagnosis and measuring the serum sIL2R levels when clinicians identify patients with new-onset SCI without any risk factors of SCI.…”
mentioning
confidence: 64%